Assessment of Knowledge of Health Workers on Haemophilia at the University of Medical Sciences Teaching Hospital, Ondo State, Nigeria
American Journal of Laboratory Medicine
Volume 5, Issue 4, July 2020, Pages: 88-94
Received: May 24, 2020; Accepted: Jun. 12, 2020; Published: Aug. 5, 2020
Views 170      Downloads 57
Authors
Osho Patrick, Department of Haematology& Blood Transfusion, Faculty of Basic Clinical Sciences, University of Medical Sciences, Ondo-City, Nigeria
Ojo Matilda, Department of Haematology& Blood Transfusion, Faculty of Basic Clinical Sciences, University of Medical Sciences, Ondo-City, Nigeria
Odunlade Olufunke, Department of Paediatrics, Faculty of Clinical Sciences, University of Medical Sciences, Ondo-City, Nigeria
Okunnuga Ndidi, Departments of Radiation and Clinical Oncology, University of Medical Sciences, Ondo-City, Nigeria
Gbenga-Fabusiwa Funmilayo, Department of Chemistry, University of Medical Sciences Teaching Hospital, Ondo, Ondo State, Nigeria
Oni Oluwatosin, Department of Haematology/Virology, University of Medical Sciences Teaching Hospital, Akure, Nigeria
Oluwole Mathew, Department of Haematology/Virology, University of Medical Sciences Teaching Hospital, Akure, Nigeria
Article Tools
Follow on us
Abstract
"Haemophilia is a rare hereditary bleeding disorder that occurs primarily among males. Adequate knowledge of its clinical presentation and management of this disorder by health workers will improve the clinical course of patients having this disorder. The study was done to assess the knowledge of clinical presentation and management of Haemophillia among health workers at the University of Medical Sciences Teaching Hospital Complex, (UNIMEDTHC) Ondo State, Nigeria. A cross sectional hospital based survey was done using questionnaires that were self-administered by the recruited respondents. Completed questionnaires were collated and analyzed with statistical package for Social Sciences Software (SPSS) version 25. A total of 194 health workers participated in the study with a response rate of 89.4%. The respondents comprised of 72 (37.1%) males and 122 (62.9%) females. Knowledge of the pathogenesis of Haemophilia among the respondents was good 178 (91.8%). Male predominance of the disorder was ascertained by 148 (76.3%) respondents. About half, 105 (54.1%) of respondents were aware that pain is a symptom among haemophiliacs. One hundred and seventy seven (91.2%) of the respondents knew that prolonged post circumcision bleeding is a symptom while 160 (82.5%) were aware that joints and muscles are mainly affected by bleeding in Haemophilia. One hundred and eighteen (60.8%) and 145 (74-4%) of the respondents were aware that HIV and Hepatitis B and C respectively were possible complications of treatment. The role of genetic counseling in prevention of Haemophillia was ascertained in 88-7% of the respondents. There is a fairly good knowledge of Haemophillia among the surveyed health workers. There is a need for improved knowledge about Haemophilia among health workers through continuing education to ensure prompt diagnosis and appropriate care of people with this disorder. "
Keywords
Assessment, Knowledge, Health Workers, Haemophilia
To cite this article
Osho Patrick, Ojo Matilda, Odunlade Olufunke, Okunnuga Ndidi, Gbenga-Fabusiwa Funmilayo, Oni Oluwatosin, Oluwole Mathew, Assessment of Knowledge of Health Workers on Haemophilia at the University of Medical Sciences Teaching Hospital, Ondo State, Nigeria, American Journal of Laboratory Medicine. Vol. 5, No. 4, 2020, pp. 88-94. doi: 10.11648/j.ajlm.20200504.12
Copyright
Copyright © 2020 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
[1]
Nazzaro AM, Owens S, Hoots WK, and Larson KL (2006). Knowledge, attitudes, and behaviors of youths in the US hemophilia population: results of a national survey. Am J Public Health. 2006; 96 (9): 1618–22.
[2]
Balogun TM, Agboola MB, Onigbinde OO, et al (2018). Haemophilia Knowledge among Health Care Providers in a Tertiary Hospital Lagos, Nigeria. Journal of Blood Disorders, Symptoms & treatments.
[3]
Valizadeh L, Hosseini FA, Zamanzadeh V, et al. (2015). Practice of Iranian Adolescents with Hemophilia in Prevention of Complications of Hemophilia. Indian J Palliat Care. 2015; 21 (3): 328-337.
[4]
Treatment of Hemophilia: Psychosocial Care for People with Hemophilia. Canada: world federation of hemophilia (WFH); 2007.
[5]
Luy J, Wu W, Xiang Z, and Huang F. (2016). Large hemorrhage due to venipuncture in the elbow of a patient with severe hemophilia: A case report and literature review. ExpTher Med. 2016; 11 (3): 1023-1026.
[6]
Zaiden RA (2017). Hemophilia B. Practice Essentials. 2017; 1-2.
[7]
Sokal EM, Lombard C, and Mazza G. Mesenchymal. (2015). Stem cell treatment for hemophilia: a review of current knowledge. J ThrombHaemost. 2015; 13 (1): S161-S166.
[8]
Karin Knobe and Erik Berntorp. Haemophillia and joint disease: pathophysiology, evaluation and management. J Comorb. 2011; 1: 51-59.
[9]
Scalone L, Mantovani LG, Mannucci PM, Gringeri A, and Cocis (2006). Study Investigators. Quality of life is associated to the orthopaedic status in haemophilic patients with inhibitors. Haemophilia. 2006; 12 (2): 154–62.
[10]
Fahimeh Alsadat Hoseini, Leila Valizadeh, Vahid Zamanzadeh, Solmaz Fallahi, and Mina Ramezan Behtash (2014). Knowledge, Attitudes and Practices of Preventing Complications among Adolescents with Severe Hemophilia. Thrita. 2014 June; 3 (2): e8758. DOI: 10.5812/thrita.8758.
[11]
Rodriguez-Merchan EC. Prevention of the Musculoskeletal Complications of Haemophillia. Advances in Preventive Medicine. 2012. https://doi.org/10.1155/2012/201271.
[12]
Report on the Universal Data Collection Program. Atlanta, Ga: Centers for Disease Control and Prevention; 2005.
[13]
Manco-Johnson MJ, Abshire TC, Brown D, et al. (2005). Initial results of a randomized, prospective trial of prophylaxis to prevent joint disease in young children with factor VIII (FVIII) deficiency. Paper presented at Annual Meeting of the American Society of Hematology, December 2005, Atlanta, Ga.
[14]
Miller KL, Guelcher C, Taylor A. Haemophilia A: patients’ knowledge level of treatment and sources of treatment-related information. Haemophilia. 2009; 15 (1): 73-77.
[15]
Witkop M, Lambing A. Knowledge and attitudes survey in bleeding disorders providers regarding pain. Haemophilia. 2015; 21 (6): e465-e471.
[16]
Drelich DA, Besa CS, Furlonf MA, et al. Hemophilia A. Practice Essentials. 2017; 1-2.
[17]
Roberts HR, Escoban M, White GC. Hemophilia A and Hemophilia B. In Lichtman AM, Beutler E, Kipps TJ, Seligsohn U, Kaushan K, Prchal TJ, (eds) Williams Haematology. 7th edition. McGraw-Hill Medical Publishing. 2006; 1867-1874.
[18]
KapilSaxena. Barriers and perceived limitations to early treatment of hemophilia. J Blood Med. 2013; 4: 49-56.
[19]
O’Mahony B, Black C. Expanding hemophilia care in developing countries. SeminThrombHemost. 2005; 31: 561–568.
[20]
Novais T, Duclos A, Varin R, Lopez I, Chamouard V. Treatment-related knowledge and skills of patients with haemophilia and their informal caregivers. Int J Clin Pharm. 2016; 38 (1): 61-69.
[21]
Srivastava A, Brewer A. K, Mauser-Bunschotem E. P, Key N. S, Kitchen S, Llinas A et al. Guidelines for the management of haemophilia. Haemophilia. 2013; 19: e1-e47.
[22]
Young G. New challenges in hemophilia: long-term outcomes and complications. Hematology Am SocHematolEduc Program. 2012; 362-368.
[23]
Palla R, Peyvandi F, Shapiro AD. Rare bleeding disorders: diagnosis and treatment. Blood. 2015; 26: 125 (13): 2052-61.
[24]
Coppola A, Morfini M, Cimino E, et al. Blood Transfus. 2014; 12 (Suppl 3): s554-s562.
[25]
Ruiz-Saez A. Comprehensive care in hemophilia. Hematology. 2012; 17: 141-144.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186